pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Age-Related Macular Degeneration in 1 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birke, K | 1 |
Lipo, E | 1 |
Birke, MT | 1 |
Kumar-Singh, R | 1 |
1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Age-Related Macular Degeneration
Article | Year |
---|---|
Topical application of PPADS inhibits complement activation and choroidal neovascularization in a model of age-related macular degeneration.
Topics: Administration, Topical; Animals; Choroidal Neovascularization; Complement Activation; Complement Me | 2013 |